Toxicity and management in CAR T-cell therapy.
Toxicity and management in CAR T-cell therapy.
复制标题
DOI:
10.1038/mto.2016.11
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
T cells can be genetically modified to target tumors through the expression of a chimeric antigen receptor (CAR). Most notably, CAR T cells have demonstrated clinical efficacy in hematologic malignancies with more modest responses when targeting solid tumors. However, CAR T cells also have the capacity to elicit expected and unexpected toxicities including: cytokine release syndrome, neurologic toxicity, “on target/off tumor” recognition, and anaphylaxis. Theoretical toxicities including clonal expansion secondary to insertional oncogenesis, graft versus host disease, and off-target antigen recognition have not been clinically evident. Abrogating toxicity has become a critical step in the successful application of this emerging technology. To this end, we review the reported and theoretical toxicities of CAR T cells and their management.
登录
查看更多内容
影响因子:
11.5
作者:
Kershaw, Michael H.;Westwood, Jennifer A.;Hwu, Patrick
通讯作者:
Hwu, Patrick
DOI:
10.1097/cji.0b013e318194a6e8
发表时间:
2009-02
期刊:
Journal of immunotherapy (Hagerstown, Md. : 1997)
影响因子:
--
作者:
Hollyman D;Stefanski J;Przybylowski M;Bartido S;Borquez-Ojeda O;Taylor C;Yeh R;Capacio V;Olszewska M;Hosey J;Sadelain M;Brentjens RJ;Rivière I
通讯作者:
Rivière I
影响因子:
17.1
作者:
Fedorov VD;Themeli M;Sadelain M
通讯作者:
Sadelain M
影响因子:
17.1
作者:
Brentjens RJ;Davila ML;Riviere I;Park J;Wang X;Cowell LG;Bartido S;Stefanski J;Taylor C;Olszewska M;Borquez-Ojeda O;Qu J;Wasielewska T;He Q;Bernal Y;Rijo IV;Hedvat C;Kobos R;Curran K;Steinherz P;Jurcic J;Rosenblat T;Maslak P;Frattini M;Sadelain M
通讯作者:
Sadelain M
影响因子:
45.3
作者:
Ahmed, Nabil;Brawley, Vita S.;Gottschalk, Stephen
通讯作者:
Gottschalk, Stephen